Loading clinical trials...
Loading clinical trials...
Phase Ib/IIa open label safety and efficacy study designed to determine the maximum tolerated dose of inhaled cisplatin liposomal (SLIT cisplatin) administered every 14 days to patients with relapsed/...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Insmed Incorporated
NCT07479732 · Osteosarcoma, Osteosarcoma Metastatic
NCT04651179 · Osteosarcoma Recurrent, Osteosarcoma Metastatic
NCT04546243 · Osteosarcoma Metastatic, Pulmonary Disease, and more
Memorial Sloan Kettering Cancer Center
New York, New York
The Albert Einstein College of Medicine Montefiore Medical Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions